Startups
Diabetes isn’t a one-size-fits-all condition, so we don’t think your insulin pump should be either. Live life on your own terms with Kaleido.
Overview
Employees
51-200
Phone
+31 88 995 5858
Founded date
2013
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 8, 2026 | ViCentra secures an additional $13M to accelerate growth and advance next-gen insulin system | Dutch-based medical device company ViCentra, which commercialises the Kaleido insulin patch pump system, has raised an additional $13 million as part of its Series D financing, bringing the total round to $98 million. The funding includes n... |
| Sep 6, 2025 | ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. Market | ViCentra, a European MedTech firm, raised $85 million in Series D funding. This capital will accelerate production and launch of its Kaleido 2 patch pump across Europe. It also prepares for critical U.S. market entry. Kaleido offers a uniqu... |
| Sep 5, 2025 | Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump | ViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4 million Series D financing to accelerate manufacturing and launch the Kaleido 2 patch pump in ... |
| Sep 3, 2025 | ViCentra Raises $85M in Series D Funding | ViCentra, a Utrecht, the Netherlands-based medical device company, raised $85M in Series D funding. The round was led by Innovation Industries, with participation from Partners in Equity and Invest-NL, EQT Life Sciences and Health Innovatio... |
| Feb 1, 2023 | ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization | Newly appointed CFO with significant experience in medical technology and public / private financing Insulin Pump system Kaleido to expand commercial roll out in Europe UTRECHT, Netherlands, Feb. 1, 2023 /PRNewswire/ -- ViCentra B.V., the c... |
| Dec 29, 2021 | These are the 21 biggest funding rounds of 2021 in the Netherlands | Over the last decade, the startup ecosystem’s value in the Netherlands has been rising fast. With a competitive talent pool, a complicated yet connected economic structure, and a booming tech sector, the Netherlands has enough reasons to be... |
| Dec 17, 2021 | ViCentra Closes USD 74M Series C Funding | ViCentra, the Utrecht, Netherlands-based company behind Kaleido, a small and light wearable insulin pump (“patch pump”), closed a EUR 65m (USD 74m) Series C financing. The round was led by new investor Partners in Equity BV, the Amsterdam b... |
| Dec 16, 2021 | Utrecht’s medtech startup ViCentra raises €65M led by Amsterdam-based VC firm Partners in Equity | Netherlands-based medical device company, ViCentra, on Thursday said it has closed Series C financing of €65M led by new investor Partners in Equity BV. The round also saw participation from existing investors LSP, INKEF Capital and Health ... |
| Jul 9, 2020 | ViCentra Closes €10M Funding Round | ViCentra, the Utrecht, Netherlands-based company behind Kaleido, a small and light insulin pump, closed a €10m funding round. The round was led by Invest-NL (€4m) with participation from existing investors INKEF Capital, LSP, Health Innovat... |
Reviews 0
FAQ about Kaleido
When was Kaleido founded?
Kaleido was founded in 2013.
What has the press written about Kaleido?
Parsers VC has collected 10 articles mentioning Kaleido, among them “ViCentra secures an additional $13M to accelerate growth and advance next-gen insulin system” (Jan 8, 2026) and “ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. Market” (Sep 6, 2025).
Is Kaleido still active?
Yes, Kaleido is active; its latest activity on Parsers VC dates from Jan 8, 2026.